Skip to content
← Full study record

NCT02489422 · ADVERSE EVENTS

Adverse events

Programs To Support You During Chemotherapy · Source last updated 2022-10-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Over 8 weeks
Other-event reporting threshold
0%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Group I (Yoga Skills Training)

Patients participate in YST consisting of four 30 minute in-person yoga sessions at weeks 2, 4, 6, and 8 that instructs skills to enhance mindfulness and promote relaxation, through instruction of awareness, movement, breathing practices, and meditation. Laboratory Biomarker Analysis: Correlative studies Questionnaire Administration: Ancillary studies Daily Survey Administration: Ancillary studies Yoga Skills Training: The YST intervention consists of four 30 minute in-person sessions that instructs skills to enhance mindfulness and promote relaxation. Participants will also be encouraged to practice daily at home. Actigraphy Assessment: Ancillary studies

4 / 231 / 232 / 23
Group II (Attention Control)

Patients participate in four 30 minute in-person sessions of supportive conversation at weeks 2, 4, 6, 8. Laboratory Biomarker Analysis: Correlative studies Questionnaire Administration: Ancillary studies Daily Survey Administration: Ancillary studies Attention Control: The AC intervention consists of four 30 minute in-person sessions of supportive conversation. In addition, the interventionist will recommend that the patients write brief diary entries daily at home. Actigraphy Assessment: Ancillary studies

3 / 212 / 212 / 21

Group identifiers: EG000: Group I (Yoga Skills Training) · EG001: Group II (Attention Control)

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      23
      num Events
      2
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      21
      num Events
      2
    term
    Death
  2. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Bowel perforation
  3. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Renal and urinary disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Acute kidney injury
  4. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Hepatobiliary disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Bile duct stenosis

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Musculoskeletal and connective tissue disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Back pain
  2. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Psychiatric disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Anxiety
  3. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Toothache
Complete source fields
event Groups
  1. deaths Num Affected
    2
    deaths Num At Risk
    23
    description
    Patients participate in YST consisting of four 30 minute in-person yoga sessions at weeks 2, 4, 6, and 8 that instructs skills to enhance mindfulness and promote relaxation, through instruction of awareness, movement, breathing practices, and meditation. Laboratory Biomarker Analysis: Correlative studies Questionnaire Administration: Ancillary studies Daily Survey Administration: Ancillary studies Yoga Skills Training: The YST intervention consists of four 30 minute in-person sessions that instructs skills to enhance mindfulness and promote relaxation. Participants will also be encouraged to practice daily at home. Actigraphy Assessment: Ancillary studies
    id
    EG000
    other Num Affected
    1
    other Num At Risk
    23
    serious Num Affected
    4
    serious Num At Risk
    23
    title
    Group I (Yoga Skills Training)
  2. deaths Num Affected
    2
    deaths Num At Risk
    21
    description
    Patients participate in four 30 minute in-person sessions of supportive conversation at weeks 2, 4, 6, 8. Laboratory Biomarker Analysis: Correlative studies Questionnaire Administration: Ancillary studies Daily Survey Administration: Ancillary studies Attention Control: The AC intervention consists of four 30 minute in-person sessions of supportive conversation. In addition, the interventionist will recommend that the patients write brief diary entries daily at home. Actigraphy Assessment: Ancillary studies
    id
    EG001
    other Num Affected
    2
    other Num At Risk
    21
    serious Num Affected
    3
    serious Num At Risk
    21
    title
    Group II (Attention Control)
frequency Threshold
0
other Events
  1. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Musculoskeletal and connective tissue disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Back pain
  2. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Psychiatric disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Anxiety
  3. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Toothache
serious Events
  1. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      2
      num At Risk
      23
      num Events
      2
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      21
      num Events
      2
    term
    Death
  2. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Bowel perforation
  3. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Renal and urinary disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      23
      num Events
      1
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      21
      num Events
      0
    term
    Acute kidney injury
  4. assessment Type
    NON_SYSTEMATIC_ASSESSMENT
    organ System
    Hepatobiliary disorders
    source Vocabulary
    CTCAE (Unspecified)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      23
      num Events
      0
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      21
      num Events
      1
    term
    Bile duct stenosis
time Frame
Over 8 weeks

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice